Chalkis Health Industry Co., Ltd

CN¥ 4.07

Last Updated 17.09.2025

Issuer Rating

4/7

Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 463.87M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks

CN¥ 4.07

Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Chalkis Health Industry Co., Ltd. produces, processes, and sells tomatoes worldwide. It offers tomato paste concentrated in drums and wooden bins, peeled and diced tomatoes, canned tomato products, tomato fiber sheets, and tomato seed oil, as well as lycopene capsules. The company was formerly known as Xinjiang Chalkis Co., Ltd. and changed its name to...

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks